| Patents for C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom (107,979) |
|---|
| 02/06/2013 | CN102911158A Crystal form of esomeprazole magnesium |
| 02/06/2013 | CN102911157A (E)-3-[2-bromo-5-(3-substituted propoxy)]phenyl-N-{4-methyl-3-[4-(pyridin-3-yl)pyrimidin-2-yl]amino}phenyl acrylamide compound |
| 02/06/2013 | CN102911117A Naphthylamine derivative and purpose thereof |
| 02/06/2013 | CN102911112A Heterocyclic compound and organic light-emitting device including the same |
| 02/06/2013 | CN102911110A N, N-disubstituted-N'-phthaloyl group-1, 3-diamine derivative and preparation method thereof |
| 02/06/2013 | CN102911103A 1-(3, N, N-disubstituted amino group propyl group)-pyrrolidone derivative and preparation method thereof |
| 02/06/2013 | CN102146074B Preparation method of pyrrole derivative and application thereof |
| 02/05/2013 | US8367844 Microbiocidal heterocycles |
| 02/05/2013 | US8367837 Process for the preparation of (R,S)-nicotine |
| 02/05/2013 | US8367836 Pyridinone antagonists of alpha-4 integrins |
| 02/05/2013 | US8367828 PPAR active compounds |
| 02/05/2013 | US8367825 Substituted pyrimidinyl oxime kinase inhibitors |
| 02/05/2013 | US8367704 Process for preparation of 2-methyl-2′ phenylpropionic acid derivatives and novel intermediate compounds |
| 02/05/2013 | US8367698 3-substituted sulfonyl piperidine derivative |
| 02/05/2013 | US8367692 Spiro (piperidine-4,2′-pyrrolidine)-1-(3,5-trifluoromethyl phenyl) methylcarboxamides as NK1 tachikynin receptor antagonists |
| 02/05/2013 | US8367688 Carbamate compounds which inhibit leukocyte adhesion mediated by VLA-4 |
| 02/05/2013 | US8367679 Biaryl carboxamides |
| 02/05/2013 | US8367674 Piperazine derivatives |
| 02/05/2013 | US8367673 Substituted diketopiperazines as oxytocin antagonists |
| 02/05/2013 | US8367669 Inhibitors of hemeprotein-catalyzed lipid peroxidation |
| 02/05/2013 | US8367666 3-carbamoyl-2-pyridone derivatives |
| 02/05/2013 | US8367664 Substituted 3-(5-membered unsaturated heterocyclyl-1, 3-dihydro-indol-2-one's and derivatives thereof as kinase inhibitors |
| 02/05/2013 | US8367653 Azetidinyl diamides as monoacylglycerol lipase inhibitors |
| 02/05/2013 | US8367038 Therameutin modulators |
| 02/05/2013 | CA2591033C Heterocyclic aspartyl protease inhibitors |
| 02/05/2013 | CA2549741C Reagent for detecting an analyte |
| 02/05/2013 | CA2526872C Fused compounds that inhibit vanilloid receptor subtype 1 (vr1) receptor |
| 02/05/2013 | CA2520894C Pyrazolidine-1,2-dicarboxyldiphenylamide derivatives as coagulation factor xa inhibitors for the treatment of thromboses |
| 02/05/2013 | CA2508792C Heterocyclic compounds, methods of making them and their use in therapy |
| 01/31/2013 | WO2013016441A1 Hiv integrase inhibitory oxoisoindoline sulfonamides |
| 01/31/2013 | WO2013016081A1 Notch pathway signaling inhibitor compound |
| 01/31/2013 | WO2013015657A2 Novel compound having angiogenesis inhibitory activity, method for preparing same, and pharmaceutical composition comprising same |
| 01/31/2013 | WO2013014448A1 2 - (2, 4, 5 - substituted -anilino) pyrimidine derivatives as egfr modulators useful for treating cancer |
| 01/31/2013 | WO2013014274A1 5ht1a antagonist useful for in vivo imaging |
| 01/31/2013 | WO2013014165A1 Substituted picolinic acids and pyrimidine-4-carboxylic acids, method for the production thereof, and use thereof as herbicides and plant growth regulators |
| 01/31/2013 | WO2013014104A1 Bis-indolic derivatives, their uses in particular as antibacterials |
| 01/31/2013 | WO2013014060A1 Substituted quinolines and their use as medicaments |
| 01/31/2013 | WO2013014039A1 Alkynyl substituted pyrimidinyl-pyrroles active as kinases inhibitors |
| 01/31/2013 | WO2013014038A1 3-oxo-2,3-dihydro-1h-indazole-4-carboxamide derivatives as parp-1 inhibitors |
| 01/31/2013 | WO2013013946A1 Dabigatran-amidoxime acid esters as prodrugs and use thereof as pharmaceuticals |
| 01/31/2013 | WO2013013817A1 Substituted heterocyclic aza derivatives |
| 01/31/2013 | WO2013013816A1 Substituted bicyclic aromatic carboxamide and urea derivatives as vanilloid receptor ligands |
| 01/31/2013 | WO2013013815A1 Substituted heteroaromatic pyrazole-containing carboxamide and urea derivatives as vanilloid receptor ligands |
| 01/31/2013 | WO2013013640A1 Quinazoline derivative, preparation method therefor, intermediate, composition and application thereof |
| 01/31/2013 | WO2013013614A1 4-(3-heteroarylarylamino)quinazoline and 1-(3-heteroarylarylamino)isoquinoline as hedgehog pathway inhibitor and use thereof |
| 01/31/2013 | WO2013013308A1 Spirocyclic molecules as protein kinase inhibitors |
| 01/31/2013 | WO2012170098A3 Arbovirus inhibitors and uses thereof |
| 01/31/2013 | US20130030188 Process for the preparation of (r,s)-nicotine |
| 01/31/2013 | US20130030187 Process for the preparation of (r,s)-nicotine |
| 01/31/2013 | US20130030186 Process for preparing sulphoxide compounds |
| 01/31/2013 | US20130030180 Methods of Facilitating Neural Cell Survival Using GDNF Family Ligand (GFL) Mimetics or RET Signaling Pathway Activators |
| 01/31/2013 | US20130030171 Pyrimidinyl Aryl Urea Derivatives being FGF Inhibitors |
| 01/31/2013 | US20130030023 Orally bioavailable dabigatran prodrugs for the treatment of diseases |
| 01/31/2013 | US20130030021 Substituted 2-(2,6-Dioxopiperidin-3-yl)-phthalimides and 1-Oxoisoindolines and Method of Reducing TNFalpha Levels |
| 01/31/2013 | US20130030019 Novel prolylcarboxypeptidase inhibitors |
| 01/31/2013 | US20130030006 Agent for preventing or treating diseases accompanied by urinary pain |
| 01/31/2013 | US20130030004 Gyrase inhibitors and uses thereof |
| 01/31/2013 | US20130030002 Fungicidal oximes and hydrazones |
| 01/31/2013 | US20130029995 Substituted Bicyclic Aromatic Carboxamide and Urea Compounds as Vanilloid Receptor Ligands |
| 01/31/2013 | US20130029994 N-(imidazolidin-2-ylidene)quinoline derivatives as modulators of alpha 2 adrenergic receptors |
| 01/31/2013 | US20130029991 New Phenylsulfamoyl Benzamide Derivatives as Bradykinin Antagonists |
| 01/31/2013 | US20130029990 Pyrazole p38 map kinase inhibitors |
| 01/31/2013 | US20130029988 Certain kynurenine-3-monooxygenase inhibitors, pharmaceutical compositions, and methods of use thereof |
| 01/31/2013 | US20130029987 Substituted diaminocarboxamide and diaminocarbonitrile pyrimidines, compositions thereof, and methods of treatment therewith |
| 01/31/2013 | US20130029981 Compounds, compositions, and methods for controlling biofilms |
| 01/31/2013 | US20130029978 Novel aryl urea derivative |
| 01/31/2013 | US20130029977 Fused substituted aminopyrrolidine derivative |
| 01/31/2013 | US20130029975 Cgrp antagonists |
| 01/31/2013 | US20130029971 Cxcr3 receptor antagonists |
| 01/31/2013 | US20130029966 Substituted oxindole derivatives, medicaments containing said derivatives and use thereof |
| 01/31/2013 | US20130029964 [5, 6] heterocyclic compound |
| 01/31/2013 | US20130029963 1,2,4-triazine-4-amine derivatives |
| 01/31/2013 | US20130029962 Substituted Heteroaromatic Pyrazole-Containing Carboxamide and Urea Compounds as Vanilloid Receptor Ligands |
| 01/31/2013 | US20130029961 Substituted Heterocyclic Aza Compounds |
| 01/31/2013 | US20130029949 Substituted Quinolines and Their Use As Medicaments |
| 01/31/2013 | US20130029948 Heterocyclic autotaxin inhibitors and uses thereof |
| 01/31/2013 | US20130029944 Inhibitors of protein kinases |
| 01/31/2013 | US20130029942 Compounds and therapeutical uses thereof |
| 01/31/2013 | US20130029941 7,11-methanocycloocta [b] quinoline derivative as highly functionalizable acetylcholinesterase inhibitors |
| 01/31/2013 | US20130028879 Method for controlling particular insect pests by applying anthranilamide compounds |
| 01/31/2013 | US20130028843 Kallikrein 7 modulators |
| 01/31/2013 | US20130025618 Novel cationic 4-aminoindoles, dye composition comprising a cationic 4-aminoindole, processes therefor and uses thereof |
| 01/31/2013 | CA2843109A1 2 - (2, 4, 5 - substituted -anilino) pyrimidine derivatives as egfr modulators useful for treating cancer |
| 01/31/2013 | CA2843022A1 Substituted quinolines and their use as medicaments |
| 01/31/2013 | CA2842983A1 Substituted heterocyclic aza derivatives |
| 01/31/2013 | CA2842976A1 Substituted bicyclic aromatic carboxamide and urea derivatives as vanilloid receptor ligands |
| 01/31/2013 | CA2842916A1 Substituted heteroaromatic pyrazole-containing carboxamide and urea derivatives as vanilloid receptor ligands |
| 01/31/2013 | CA2842841A1 Spirocyclic molecules as protein kinase inhibitors |
| 01/31/2013 | CA2842830A1 Substituted picolinic acids and pyrimidine-4-carboxylic acids, method for the production thereof,and use thereof as herbicides and plant growth regulators |
| 01/31/2013 | CA2842508A1 Bis-indolic derivatives, their uses in particular as antibacterials |
| 01/31/2013 | CA2842304A1 Dabigatran-amidoxime acid esters as prodrugs and use thereof as pharmaceuticals |
| 01/31/2013 | CA2841178A1 Notch pathway signaling inhibitor compound |
| 01/30/2013 | EP2551268A1 Process for the preparation of moxifloxacin hydrochloride and intermediates thereof |
| 01/30/2013 | EP2550966A1 Amidoxime carboxylic acid esters of dabigatran as prodrugs and their use as medicaments |
| 01/30/2013 | EP2550267A1 Analogues for the treatment or prevention of flavivirus infections |
| 01/30/2013 | EP2550266A2 Heterocyclic compounds useful for kinase inhibition |
| 01/30/2013 | EP2550262A1 Analogues for the treatment or prevention of flavivirus infections |
| 01/30/2013 | EP2550260A1 Compositions and methods for the treatment of degenerative diseases |
| 01/30/2013 | EP2550257A1 Pharmaceutically active disubstituted triazine derivatives |
| 01/30/2013 | EP2550255A1 Imaging agents for detecting neurological disorders |